Randomized Trial Comparing Laparoscopic Roux-en-y Gastric Bypass to Micro-laparoscopic Roux-en-y Gastric Bypass

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Danbury Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Ethicon Endo-Surgery
Information provided by:
Danbury Hospital
ClinicalTrials.gov Identifier:
NCT01183273
First received: August 9, 2010
Last updated: June 27, 2011
Last verified: June 2011

August 9, 2010
June 27, 2011
March 2010
March 2012   (final data collection date for primary outcome measure)
Safety of micro-laparoscopic versus laparoscopic gastric bypass [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01183273 on ClinicalTrials.gov Archive Site
  • Postoperative pain [ Time Frame: 30 days ] [ Designated as safety issue: No ]
  • Time off from work [ Time Frame: 30 days ] [ Designated as safety issue: No ]
  • Operating Cost [ Time Frame: The time of surgery is collected following patient discharge approximately 4 to 5 days ] [ Designated as safety issue: No ]
  • Time of Surgery [ Time Frame: The time of surgery is collected following patient discharge approximately 4 to 5 days. ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Randomized Trial Comparing Laparoscopic Roux-en-y Gastric Bypass to Micro-laparoscopic Roux-en-y Gastric Bypass
Prospective Randomized Trial Comparing Laparoscopic Roux-en-y Gastric Bypass to Micro-laparoscopic Roux-en-y Gastric Bypass

Background Laparoscopy is the preferred surgical approach for a number of different diseases as it allows for diagnosis and treatment in the setting of a safe and feasible method offering enhanced cosmesis. The natural evolution of laparoscopy is micro-laparoscopy which utilizes smaller instruments and optics. Technological advancements have enabled miniaturization of the surgical equipment without compromising diagnostic or operative capabilities.

Dr. Keith Zuccala is currently performing micro-laparoscopic gastric bypass with an identical safety profile as traditional laparoscopy (NSQIP data comparison between Dr. Laura Choi and Dr. Keith Zuccala). The current trend in laparoscopy is to minimize incisions and their size to decrease trauma to the abdominal wall.

Study Design Both methods have never been compared in a prospective randomized trial to address the following questions.

  1. Is there a difference in outcome?
  2. Is there a decrease in postoperative pain?
  3. Does it decrease time off from work?
  4. Does micro-laparoscopy increase OR time?
  5. What is the effect on cost of micro-laparoscopy? Patients will be randomized to one or the other method, disclosing that to the investigators best knowledge both methods are equally safe and that Dr. Zuccala has performed several hundred cases using both methods.

Patient Population Projected sample size would be 50 patients in each group. Accrual should be feasible over the course of 9-12 months.

Data collection (patients will be followed for a total of 30 days for the purpose of this study)

  1. NSQIP data to assess outcome
  2. Postoperative usage of pain medication while in the hospital
  3. Time off from work
  4. OR time
  5. Direct cost of procedure as it relates to material used

This study compares two groups of patients who have voluntarily chosen to undergo roux-n-y gastric bypass surgery. The groups will be randomized to receive micro-laparoscopic or laparoscopic surgery to be performed by the same surgeon, Dr. Keith Zuccala.

Study Schema

  • The patient attends an informational seminar conducted by the Bariatric Surgery Department
  • The patient is scheduled for an initial consultation with the bariatric PA/NP where the patient provides: a letter of referral for Bariatric Surgery from primary care doctor or specialty physician; insurance referral; and assurance that health insurance coverage includes Bariatric Surgery.
  • Following the initial consultation, the patient is scheduled for the following: comprehensive blood testing; psychological screening/evaluation; dietary evaluation; appointment with the surgeon; pulmonary evaluation (if needed); cardiology evaluation (if needed); gastroenterology evaluation (if needed).
  • An appointment for medical clearance with the referring surgeon is scheduled and completed within three weeks of surgery. At this appointment an electrocardiogram (EKG) and repeat blood work will be carried out.
  • The patient is deemed to meet all inclusion criteria.
  • The patient is advised to follow all pre-operative instructions as advised by the nursing staff and explained in the Danbury Hospital Center for Weight Loss Surgery Guide.
  • Surgical procedures performed are standard for those already utilized daily in the surgery department for gastric bypass procedures.
  • The patient is closely observed in the hospital and given specific discharge instructions upon leaving the hospital
  • The patient is followed for a maximum of 60 days after surgery and asked how many days of work they missed.
  • The NSQIP data base and patient medical record are used to assess outcome, postoperative pain, OR time and surgery cost
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Obesity
  • Procedure: Microlaparoscopic gastric bypass
    microlaparoscopic gastric bypass will be performed using standard of care procedure.
  • Procedure: Laparoscopic Surgery
    laparoscopic gastric bypass will be performed using standard of care procedure.
  • Active Comparator: Micro-laparoscopic bypass
    Intervention: Procedure: Microlaparoscopic gastric bypass
  • Active Comparator: Laparoscopic gastric bypass
    Intervention: Procedure: Laparoscopic Surgery
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
100
September 2012
March 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • A body mass index (BMI) ≥ 40 with or without co-morbid conditions*
  • A BMI ≥ 35 with co-morbid conditions*
  • Permanent lifestyle changes including exercise
  • No significant, untreated psychiatric illnesses
  • Age ≥ 18 years
  • Sufficient ability and cognition to understand surgery, potential complications and subsequent associated changes
  • Willingness to participate in treatment and long-term follow-up
  • Proof of failed attempts at non-surgical weight reduction
  • Acceptable medical/operative risks * Co-morbid solutions include: hypertension, diabetes mellitus, cardiac disease, hypercholesterolemia/hyperlipidemia, sleep apnea, asthma, hypoventilation syndrome of obesity, degenerative joint disease, gastro-esophageal reflux disease, venous stasis ulcers, depression, menstrual irregularities/infertility, polycystic ovary syndrome, fungal skin infections.

Exclusion Criteria:

  • The need to convert from laparoscopic roux-n-y to an open abdominal procedure.
  • Patients with congestive heart failure or other serious illness which would prevent the patient from a successful surgery and recovery
  • Women who are nursing or pregnant
  • Patients who smoke
  • Patient's insurance will not cover the cost of surgery.
Both
18 Years and older
No
Not Provided
United States
 
NCT01183273
29043
No
Pierre F. Saldinger, M.D./ Chairman, Department of Surgery, Danbury Hospital
Danbury Hospital
Ethicon Endo-Surgery
Study Chair: Pierre Saldinger, M.D. Danbury Hospital
Principal Investigator: Keith Saldinger, M.D. Danbury Hospital
Study Director: Suzanne J House, M.S., Ph.D. Danbury Hospital
Danbury Hospital
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP